These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 6239934

  • 1. [Changes of hormone receptor status in various treatment for human breast cancer and DMBA tumor of the rat].
    Iino Y, Yamazaki K, Ishikawa H, Endo K, Arai T, Ogawa T, Hoshino K, Ishida T, Yokoe T, Takahashi T.
    Gan No Rinsho; 1984 Oct; 30(13):1633-7. PubMed ID: 6239934
    [Abstract] [Full Text] [Related]

  • 2. [Effect of medroxyprogesterone acetate (MAP) and vitamin C on DMBA induced rat mammary cancer in relation to estrogen receptor(ER)].
    Iino Y, Yamazaki K, Ogawa T, Hirai T, Arai T, Ishikawa H, Endo K, Kawai T, Izuo M, Takikawa H.
    Gan No Rinsho; 1983 Aug; 29(9):949-54. PubMed ID: 6225884
    [Abstract] [Full Text] [Related]

  • 3. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
    Viale G, Regan MM, Maiorano E, Mastropasqua MG, Golouh R, Perin T, Brown RW, Kovács A, Pillay K, Ohlschlegel C, Braye S, Grigolato P, Rusca T, Gelber RD, Castiglione-Gertsch M, Price KN, Goldhirsch A, Gusterson BA, Coates AS.
    J Clin Oncol; 2008 Mar 20; 26(9):1404-10. PubMed ID: 18349391
    [Abstract] [Full Text] [Related]

  • 4. Chemoendocrine therapy in DMBA-induced rat mammary carcinoma.
    Morimoto T, Yamamoto H, Komaki K, Konishi N, Tanaka T, Yamakawa T, Mori T, Sasa M, Monden Y.
    Tokushima J Exp Med; 1990 Dec 20; 37(3-4):59-68. PubMed ID: 2128782
    [Abstract] [Full Text] [Related]

  • 5. Effective sequential administration of tamoxifen and medroxyprogesterone acetate for 7,12-dimethylbenz[a-anthracene-induced rat mammary tumors in relation to hormone receptors.
    Tominaga T, Yoshida Y, Kitamura M, Kosaki G.
    Jpn J Cancer Res; 1985 Nov 20; 76(11):1120-5. PubMed ID: 2935517
    [Abstract] [Full Text] [Related]

  • 6. Steroid hormone receptors and response to high-dose medroxyprogesterone acetate in advanced breast cancer.
    Nomura Y, Tashiro H, Hisamatsu K, Shinozuka K.
    Anticancer Res; 1988 Nov 20; 8(4):647-51. PubMed ID: 2972248
    [Abstract] [Full Text] [Related]

  • 7. Sequential hormone therapy with medroxyprogesterone acetate for 7, 12-dimethylbenz [alpha] anthracene-induced rat mammary tumors.
    Iino Y, Ishikawa H, Izuo M, Takikawa H.
    Jpn J Clin Oncol; 1989 Mar 20; 19(1):45-50. PubMed ID: 2522157
    [Abstract] [Full Text] [Related]

  • 8. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
    Regan MM, Viale G, Mastropasqua MG, Maiorano E, Golouh R, Carbone A, Brown B, Suurküla M, Langman G, Mazzucchelli L, Braye S, Grigolato P, Gelber RD, Castiglione-Gertsch M, Price KN, Coates AS, Goldhirsch A, Gusterson B, International Breast Cancer Study Group.
    J Natl Cancer Inst; 2006 Nov 01; 98(21):1571-81. PubMed ID: 17077359
    [Abstract] [Full Text] [Related]

  • 9. [Effects of high-dose medroxyprogesterone acetate in advanced breast cancer, with special reference to prior endocrine therapy and hormone receptors].
    Nomura Y, Tashiro H, Hisamatsu K, Toi M.
    Gan To Kagaku Ryoho; 1988 Mar 01; 15(3):513-8. PubMed ID: 2964811
    [Abstract] [Full Text] [Related]

  • 10. [Hormone receptors: clinical significance and problems in the treatment of breast cancer].
    Izuo M, Iino Y.
    Gan No Rinsho; 1983 May 01; 29(6):637-43. PubMed ID: 6876433
    [Abstract] [Full Text] [Related]

  • 11. [Combined therapies with medroxyprogesterone acetate (MPA) in DMBA-induced rat mammary cancer].
    Ishikawa H, Iino Y, Izuo M, Takikawa H.
    Gan No Rinsho; 1986 Feb 01; 32(2):151-5. PubMed ID: 2937941
    [Abstract] [Full Text] [Related]

  • 12. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes.
    Carey LA, Dees EC, Sawyer L, Gatti L, Moore DT, Collichio F, Ollila DW, Sartor CI, Graham ML, Perou CM.
    Clin Cancer Res; 2007 Apr 15; 13(8):2329-34. PubMed ID: 17438091
    [Abstract] [Full Text] [Related]

  • 13. [Ultrastructural study of rat mammary tumors and human breast cancer cells following treatment with tamoxifen].
    Kamioki S.
    Gan No Rinsho; 1986 Nov 15; 32(14):1809-18. PubMed ID: 3099030
    [Abstract] [Full Text] [Related]

  • 14. Effects of tamoxifen, estradiol benzoate and medroxyprogesterone acetate on the growth of DMBA-induced rat mammary carcinoma.
    Zanardi S, De Menech R, Pino G, Guarneri D, Dandolo G, Sanguineti M, Moro MG, Barbi GP, Paganuzzi M, Boccardo F.
    Chemioterapia; 1985 Jun 15; 4(3):239-42. PubMed ID: 3161642
    [Abstract] [Full Text] [Related]

  • 15. Effects of medroxyprogesterone acetate on DMBA-induced mammary tumors.
    Racca S, Conti G, Crispino A, Gallo E, Di Carlo F.
    Chemioterapia; 1985 Jun 15; 4(3):236-8. PubMed ID: 3928182
    [Abstract] [Full Text] [Related]

  • 16. [Relation between hormone dependency and the estrogen receptor of mammary carcinoma--comparative study of rat and human mammary tumors].
    Iwasa Z, Yamamoto M, Tanaka A, Okuno K, Sagara N, Matsuda T, Fukuhara T, Yasutomi M.
    Gan No Rinsho; 1985 Dec 15; 31(15):1865-70. PubMed ID: 3937916
    [Abstract] [Full Text] [Related]

  • 17. [Effects of neoadjuvant chemotherapy on estrogen and progesterone receptors and HER-2 in breast cancer].
    Zhao J, Wu YL, Wang YD, Zhao GR, Wang J.
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Dec 15; 24(12):1437-9. PubMed ID: 15604081
    [Abstract] [Full Text] [Related]

  • 18. Prognostic predictors in breast cancer patients with postoperative 5-fluorouracil-based chemotherapy.
    Hakamada Y, Tsuchida A, Arima M, Kubouchi T, Tokita H, Ota D, Kaise H, Aoki T, Kusama M, Aoki T.
    Int J Mol Med; 2005 Aug 15; 16(2):309-14. PubMed ID: 16012767
    [Abstract] [Full Text] [Related]

  • 19. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G, Kalogeras KT, Wirtz RM, Grimani I, Zografos G, Gogas H, Stropp U, Pectasides D, Skarlos D, Hennig G, Samantas E, Bafaloukos D, Papakostas P, Kalofonos HP, Pavlidis N, Fountzilas G.
    Breast Cancer Res Treat; 2009 Jul 15; 116(1):131-43. PubMed ID: 18668363
    [Abstract] [Full Text] [Related]

  • 20. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.
    BMC Cancer; 2007 Apr 12; 7():63. PubMed ID: 17430582
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.